R&D expense · 2011–2025
Resmed R&D expense
$331M+7.7% · FY2025
Resmed (RMD) reported $331M in R&D expense for fiscal 2025, +7.7% year on year.
| Fiscal year | R&D expense | Change | Filing |
|---|---|---|---|
| FY20252025-06-30 | $331M | +7.7% | Open → |
| FY20242024-06-30 | $308M | +6.9% | Open → |
| FY20232023-06-30 | $288M | +13.4% | Open → |
| FY20222022-06-30 | $254M | +12.6% | Open → |
| FY20212021-06-30 | $225M | +11.6% | Open → |
| FY20202020-06-30 | $202M | +11.8% | Open → |
| FY20192019-06-30 | $181M | +16.4% | Open → |
| FY20182018-06-30 | $155M | +7.4% | Open → |
| FY20172017-06-30 | $144M | +21.8% | Open → |
| FY20162016-06-30 | $119M | +3.3% | Open → |
| FY20152015-06-30 | $115M | −2.8% | Open → |
| FY20142014-06-30 | $118M | −1.6% | Open → |
| FY20132013-06-30 | $120M | +9.5% | Open → |
| FY20122012-06-30 | $110M | +19.3% | Open → |
| FY20112011-06-30 | $92.0M | — | Open → |
R&D expense — Research and development expense is what the company charged to R&D in the income statement for the year. Most companies report no R&D at all — the line is absent rather than zero — so this ranking covers the roughly 40% of filers that do.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +9.6%
R&D expense at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Resmed R&D expense |url=https://companiesranked.com/en/company/resmed/research-and-development-expense |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Resmed R&D expense. CompaniesRanked. https://companiesranked.com/en/company/resmed/research-and-development-expenseBibTeX
@misc{companiesranked-en-company-resmed-research-and-development-expense-2026,
author = {{CompaniesRanked}},
title = {{Resmed R\&D expense}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/resmed/research-and-development-expense}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0000943819-26-000047 · August 13, 2026
{{cite web |title=Resmed R&D expense — 10-K (0000943819-26-000047) |url=https://www.sec.gov/Archives/edgar/data/943819/000094381926000047/rmd-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-13}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.